Katsushige Abe Selected Research

chlorhexidine gluconate (Dyna-Hex)

7/2021	An inhibitor of Krüppel-like factor 5 suppresses peritoneal fibrosis in mice.
4/2013	Involvement of leptin in the progression of experimentally induced peritoneal fibrosis in mice.
3/2013	22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.
7/2012	HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice.
1/2012	Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model.
4/2011	Thalidomide prevents the progression of peritoneal fibrosis in mice.
10/2004	TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.
9/2003	Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats.
1/2003	Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsushige Abe Research Topics

Disease

11	Peritoneal Fibrosis 07/2021 - 01/2003
6	Glomerulonephritis 12/2012 - 07/2003
4	Fibrosis (Cirrhosis) 04/2013 - 01/2008
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2005 - 07/2003
2	Type 2 Diabetes Mellitus (MODY) 04/2020 - 12/2014
2	Stroke (Strokes) 03/2019 - 12/2008
2	Inflammation (Inflammations) 04/2013 - 09/2008
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2005 - 07/2003
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2005 - 07/2003
1	Periodontitis 04/2020
1	Peripheral Arterial Disease 03/2019
1	Diabetes Complications 03/2019
1	Hearing Loss (Hearing Impairment) 03/2019
1	Foot Ulcer 03/2019
1	Blindness (Hysterical Blindness) 03/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2019
1	Gangrene 03/2019
1	Secondary Hyperparathyroidism 03/2013
1	Hepatitis 03/2013
1	Cystic Fibrosis (Mucoviscidosis) 03/2013
1	Chronic Disease (Chronic Diseases) 03/2013
1	Chronic Renal Insufficiency 01/2012
1	Multiple Myeloma 04/2011
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 09/2008
1	Iron Deficiencies 09/2008
1	Anemia 09/2008
1	Disease Progression 01/2008
1	Heart Arrest (Cardiac Arrest) 01/2008
1	Acute Kidney Injury (Acute Renal Failure) 01/2008
1	Rhabdomyolysis 01/2008
1	Poisoning 01/2008
1	Arthritis (Polyarthritis) 12/2005
1	Urinary Tract Infections (Urinary Tract Infection) 12/2005
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2005
1	Hematuria 12/2004
1	Proteinuria 12/2004

Drug/Important Bio-Agent (IBA)

9	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 07/2021 - 01/2003
4	HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA 12/2012 - 01/2003
4	CollagenIBA 07/2012 - 01/2003
3	Snake Venoms (Snake Venom)IBA 12/2012 - 07/2008
2	CreatinineIBA 04/2020 - 12/2005
2	Collagen Type III (Type III Collagen)IBA 03/2013 - 12/2008
2	Small Interfering RNA (siRNA)IBA 07/2012 - 01/2008
2	Angiotensin IIIBA 01/2012 - 01/2005
2	Immunoglobulin A (IgA)IBA 01/2005 - 07/2003
1	Factor V (Coagulation Factor V)IBA 07/2021
1	tamibaroteneIBA 07/2021
1	AlbuminsIBA 04/2020
1	Liraglutide FDA Link 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	LeptinIBA 04/2013
1	CalciumIBA 03/2013
1	maxacalcitolIBA 03/2013
1	Vitamin D FDA LinkGeneric 03/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2012
1	VenomsIBA 12/2012
1	Collagen Type IV (Type IV Collagen)IBA 12/2012
1	Proto-Oncogene Protein c-ets-1IBA 12/2012
1	GelatinIBA 07/2012
1	Type 1 Angiotensin ReceptorIBA 01/2012
1	Thalidomide (Thalomid)FDA Link 04/2011
1	Oxidoreductases (Dehydrogenase)IBA 12/2008
1	NADP (NADPH)IBA 12/2008
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 12/2008
1	NAD (NADH)IBA 12/2008
1	azelnidipineIBA 12/2008
1	olmesartanIBA 12/2008
1	Hydralazine (Apresoline)FDA LinkGeneric 12/2008
1	Ferritins (Ferritin)IBA 09/2008
1	Erythropoietin FDA Link 09/2008
1	HepcidinsIBA 09/2008
1	Transferrin (beta 2 Transferrin)IBA 09/2008
1	IronIBA 09/2008
1	Antimicrobial PeptidesIBA 09/2008
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	palytoxinIBA 01/2008
1	Pharmaceutical PreparationsIBA 11/2006
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2006
1	Complement System Proteins (Complement)IBA 03/2006
1	AngiotensinsIBA 01/2005
1	EnzymesIBA 01/2005
1	Chymases (Chymase)IBA 01/2005
1	ReninIBA 01/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2005
1	Angiogenesis InhibitorsIBA 10/2004
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 10/2004

Therapy/Procedure

4	Intraperitoneal Injections 07/2021 - 01/2003
3	Peritoneal Dialysis 01/2012 - 10/2004
2	Therapeutics 09/2008 - 01/2003
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2003 - 01/2003
1	Glycemic Control 03/2019
1	Surgical Amputation (Amputations) 03/2019
1	Microspheres (Microsphere) 07/2012
1	Renal Dialysis (Hemodialysis) 09/2008
1	Hemodiafiltration 01/2008
1	Tonsillectomy 12/2004